DCTH vs. INMD, CDRE, MDXG, RXST, BLFS, AORT, EMBC, PLSE, LQDA, and ESTA
Should you be buying Delcath Systems stock or one of its competitors? The main competitors of Delcath Systems include InMode (INMD), Cadre (CDRE), MiMedx Group (MDXG), RxSight (RXST), BioLife Solutions (BLFS), Artivion (AORT), Embecta (EMBC), Pulse Biosciences (PLSE), Liquidia (LQDA), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.
Delcath Systems vs.
Delcath Systems (NASDAQ:DCTH) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, community ranking, dividends, analyst recommendations and institutional ownership.
InMode has a net margin of 36.26% compared to Delcath Systems' net margin of -150.70%. InMode's return on equity of 21.46% beat Delcath Systems' return on equity.
61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 17.9% of Delcath Systems shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
InMode received 129 more outperform votes than Delcath Systems when rated by MarketBeat users. Likewise, 73.85% of users gave InMode an outperform vote while only 26.89% of users gave Delcath Systems an outperform vote.
InMode has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.
In the previous week, Delcath Systems had 9 more articles in the media than InMode. MarketBeat recorded 12 mentions for Delcath Systems and 3 mentions for InMode. Delcath Systems' average media sentiment score of 0.63 beat InMode's score of 0.62 indicating that Delcath Systems is being referred to more favorably in the media.
Delcath Systems currently has a consensus target price of $22.25, indicating a potential upside of 55.49%. InMode has a consensus target price of $22.40, indicating a potential upside of 33.41%. Given Delcath Systems' stronger consensus rating and higher probable upside, equities research analysts clearly believe Delcath Systems is more favorable than InMode.
Delcath Systems has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, InMode has a beta of 2.12, meaning that its stock price is 112% more volatile than the S&P 500.
Summary
InMode beats Delcath Systems on 11 of the 18 factors compared between the two stocks.
Get Delcath Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Delcath Systems Competitors List
Related Companies and Tools
This page (NASDAQ:DCTH) was last updated on 1/18/2025 by MarketBeat.com Staff
Free DCTH Stock Alerts